Start Date: 06/09/2017

End Date: 06/09/2017

Cost: 180

Venue: The Royal Marsden Education and Conference Centre

Organiser:

The Royal Marsden Education and Conference Team

Contact Details:

conferencecentre@rmh.nhs.uk

020 7808 2921

The Conference Team The Royal Marsden NHS
Foundation Trust, Stewarts Grove, London SW3 6JJ

 

Comments:

This one day course will examine the relevance of genetic test results for management of oncology patients. Each will focus on a case and the audience will have an opportunity to ask questions about each case. The learning objectives of the course is an appreciation of the contribution of genetic results for planning treatment, prognostic indicators, assessing future cancer risk and planning long term cancer surveillance for the patient as well as understanding the relevance of genetic testing for patients’ relatives. The course will cover colorectal cancer, breast cancer, gynae cancer and endocrine cancer cases.

Link: www.royalmarsden.nhs.uk/news-and-events/conference-centre/study-days-and-conferences/integrating-inherited-cancer-syndromes

    Latest News

  • ClinGen/ACGS collaboration

    posted 5th February 2018  |  0 Comments

    Association for Clinical Genomic Science (ACGS) has entered into a formal affiliation with the ClinGen Inherited Cardiomyopathy Expert Panel (CMP-EP). We will be working jointly to adapt the ACMG/AMP variant classification guidelines for genes associated with hypertrophic cardiomyopathy (HCM). This work is an extension of the ClinGen CMP-EP's recommendations for MYH7 variant classification. ClinGen and ACGS have a shared goal of developing standardised genomic variant interpretation guidelines for improved patient care. The contribution of genomic and phenotypic data from both groups, as well as collaboration in the decision-making process, represents a first step in global development, acceptance, and use of a common set of specified guidelines.

    Read more